Výsledky vyhledávání - "Werner, Baurecht"

Frühe vs. spätere Therapie mit Abirateron plus Prednison bei chemotherapie-naiven, asymptomatischen bis mild symptomatischen Patienten mit metastasiertem CRPC nach Androgendeprivation

Autor: Martin Bögemann, Nguyen Tran, Philipp Spiegelhalder, Hanjo Belz, Susan Feyerabend, Christoph Rüssel, Werner Baurecht, Axel S. Merseburger, Katrin Kruetzfeldt

Publikováno v: Aktuelle Urologie. 51:562-571

Zusammenfassung Hintergrund Abirateronacetat (AA) ist ein Prodrug von Abirateron, einem irreversiblen Inhibitor der 17α-Hydroxylase/C17, 20-lyase. Seit 2011 steht Abirateronacetat in Kombination mit Prednison/Prednisolon (AA + P) zur Therapie des me

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d243d10abda9dfc743ff6f757db65332
https://doi.org/10.1055/a-1121-7593

Zobrazit plný text záznamu

Adherence Measures for Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone Acetate plus Prednisone: Results of a Prospective, Cluster-Randomized Trial

Autor: Katrin Krützfeldt, Werner Baurecht, Susan Feyerabend, Hussein Sweiti, Andreas Huebner, Tim Mathes, Jochen Gleissner, Henrik Suttmann

Publikováno v: Cancers, Vol 12, Iss 2550, p 2550 (2020)
Cancers
Volume 12
Issue 9

Simple Summary We report the final results of a multicenter, prospective, 2-arm trial in a real world setting for patients with metastatic castration resistant prostate cancer. A number of 675 patients were allocated by center-based cluster-randomiza

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3571de8031a6409f72ceeeb9c51eb94
https://www.mdpi.com/2072-6694/12/9/2550

Zobrazit plný text záznamu

[Early- vs. late-onset treatment using abiraterone acetate plus prednisone in chemo-naïve, asymptomatic or mildly symptomatic patients with metastatic CRPC after androgen deprivation therapy]

Autor: Axel S, Merseburger, Christoph, Rüssel, Hanjo, Belz, Philipp, Spiegelhalder, Susan, Feyerabend, Nguyen, Tran, Katrin, Kruetzfeldt, Werner, Baurecht, Martin, Bögemann

Publikováno v: Aktuelle Urologie. 51(6)

Abiraterone acetate (AA) is a prodrug of abiraterone, which is an irreversible inhibitor of 17α-hydroxylase/C17, 20-lyase. Since 2011, abiraterone acetate has been available in combination with prednisone/prednisolone (AA + P) for the treatment of m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::104c79779b3d226141b8228f3434f0ff
https://pubmed.ncbi.nlm.nih.gov/32268436

Zobrazit plný text záznamu

[Tolerability, compliance, quality of life, and clinical outcome during treatment with quinine sulfate in patients with nocturnal calf cramps. A multicenter non-interventional study (NIS) in adults]

Autor: Hans-Christoph, Diener, Werner, Baurecht

Publikováno v: MMW Fortschritte der Medizin. 161(Suppl 6)

Frequent and painful nocturnal leg cramps (NLC) require an effective therapy to improve quality of life and sleep performance in patients.In a multicenter, prospective, non-interventional study (NIS) data on the effectiveness, tolerability and safety

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0d009e2ef3264a81dfaad9b331512e32
https://pubmed.ncbi.nlm.nih.gov/31587167

Zobrazit plný text záznamu

Adherence enhancing program for patients with metastatic, castration-resistant prostate carcinoma treated with abiraterone acetate plus prednisone: A cluster randomized trial

Autor: Jochen Gleissner, Susan Feyerabend, Andreas Hübner, Katrin Krützfeldt, Tim Mathes, Henrik Suttmann, Hussein Sweiti, Werner Baurecht

Publikováno v: Journal of Clinical Oncology. 37:e16520-e16520

e16520 Background: Abiraterone acetate plus prednisone (AA+P) is an effective treatment for patients (pts) with metastatic, castration-resistant prostate carcinoma (mCRPC). Adherence is an important factor for the success of AA+P treatment. Research

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::edbe1e67174d73cbaf3b6e85edcac409
https://doi.org/10.1200/jco.2019.37.15_suppl.e16520

Zobrazit plný text záznamu

Effect of simvastatin and/or pioglitazone on insulin resistance, insulin secretion, adiponectin, and proinsulin levels in nondiabetic patients at cardiovascular risk—the PIOSTAT Study

Autor: Thomas Forst, Carsta Koehler, E. Karagiannis, Markolf Hanefeld, Georg Lübben, Nikolaus Marx, Marc Weber, C. Hohberg, Werner Baurecht, Andreas Pfützner

Publikováno v: Metabolism. 56:491-496

We investigated the effect of pioglitazone in comparison with and in combination with simvastatin on insulin resistance, plasma adiponectin, postprandial plasma glucose, insulin, and intact proinsulin levels in a nondiabetic population at cardiovascu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c2f3b7f131655572af552d635b7ce4b
https://doi.org/10.1016/j.metabol.2006.11.007

Zobrazit plný text záznamu

Anti-Inflammatory Effects of Pioglitazone and/or Simvastatin in High Cardiovascular Risk Patients With Elevated High Sensitivity C-Reactive Protein

Autor: Ulf Stier, Georg Lübben, Markolf Hanefeld, Werner Baurecht, E. Karagiannis, Nikolaus Marx, Thomas Forst, Andreas Pfützner

Publikováno v: Journal of the American College of Cardiology. 49:290-297

Objectives The purpose of this study was to test the safety and efficacy of pioglitazone and simvastatin in combination versus each drug individually in non-diabetic subjects with cardiovascular disease (CVD) and elevated high-sensitivity C-reactive

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68cd57c8e6aa44f3ac55383a447c6f2d
https://doi.org/10.1016/j.jacc.2006.08.054

Zobrazit plný text záznamu

Prospective, randomized, controlled, and open study in primarily inoperable, stage III non-small cell lung cancer (NSCLC) patients given sequential radiochemotherapy with or without epoetin alfa

Autor: Peter Drings, Ralf Angermund, Jürgen Debus, Werner Baurecht

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 112(1)

Induction chemotherapy is associated with anemia in non-small cell lung cancer (NSCLC) patients undergoing radiotherapy. This randomized, open-label study compared the effect of sequential radiochemotherapy (RCHT) versus RCHT + epoetin alfa (RCHT + E

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48d228aa07cf085bc93e17fe6860a121
https://pubmed.ncbi.nlm.nih.gov/25129551

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání